Antitrust + Competition Life Sciences Quarterly Update - Q1 2022 | Goodwin
Despite the aggressive rhetoric, the change in the leadership and composition at the U.S. Federal Trade Commission (FTC) did not result in more enforcement in 2021. As the calendar...
Source: jdsupra.com